Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s221877
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 2019
Authors
Publisher
Informa UK Limited